Benlysta (belimumab) - GSK
Lupkynis (voclosporin) - Aurinia Pharmaceuticals
mycophenolate mofetil - Generic mfg.
Voclosporin for the treatment of lupus nephritis flares in patients with inadequate response to mycophenolate mofetil and belimumab: a case series. (PubMed, J Nephrol) - Aug 13, 2026 - "Finally, the third report describes a woman who developed an LN flare shortly after starting belimumab. In all three cases, voclosporin effectively controlled LN relapses, with treatment generally being well tolerated and no clinically relevant adverse events observed, highlighting its potential role in treating nephrotic LN flares, as suggested by the most recently published treatment guidelines." 
Journal • Acute Kidney Injury • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Renal Disease • Systemic Lupus Erythematosus
http://www.ncbi.nlm.nih.gov/pubmed/42584031
 
Alessandra Bortoluzzi; Elena Pollicelli; Ettore Silvagni; Laura Scichilone; Marcello Govoni; Riccardo Bertola
 
Aug 13, 2026
 
Prev Next